Navigation Links
Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO

CAMBRIDGE, Mass. and GAITHERSBURG, Md., May 31, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune, Inc. (Nasdaq:MEDI) today announced that interim clinical data on IPI-504 in a Phase I trial in patients with gastrointestinal stromal tumors (GIST) and other soft tissue sarcomas (STS), will be presented at the 2007 Annual Meeting of the American Society of Clinical Oncology (ASCO), to be held June 1-5, 2007 at McCormick Place in Chicago, Ill. IPI-504, the companies' heat shock protein 90 (Hsp90) inhibitor, is currently being evaluated as a water-soluble, intravenous formulation in two disease-focused clinical trials involving patients with GIST/STS and non-small cell lung cancer (NSCLC).

* A poster entitled, "Inhibition and flare patterns of metabolic response to the heat shock protein 90 (Hsp90) inhibitor IPI-504 visualized by FDG-PET in patients (pts) with advanced gastrointestinal stromal tumors (GIST) resistant to tyrosine kinase inhibitor (TKI) therapy," (Poster Number 1, Abstract No: 3530) will be presented on Saturday, June 2, 2007 from 2:00-6:00 p.m. CDT in Room S102a.

* A poster entitled, "Inhibition of the Heat Shock Protein 90 (Hsp90) chaperone with the novel agent IPI-504 to overcome resistance to tyrosine kinase inhibitors (TKIs) in metastatic GIST: Updated results of a phase I trial," (Poster Number 8, Abstract No: 10023) will be presented on Monday, June 4, 2007 from 2:00-6:00 p.m. CDT in Room S103a.

About IPI-504

IPI-504 is a small molecule drug candidate being developed jointly by Infinity and MedImmune. IPI-504 has been well tolerated in its ongoing Phase I studies and has shown promising biological activity in a Phase I clinical trial in patients with relapsed, refractory, Gleevec(r)-resistant GIST. IPI-504 is also being evaluated in a Phase I/II clinical trial in patients with advanced NSCLC. In preclinical studies, IPI-504 has been
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Infinity and MedImmune Announce Updated Data Ipi Presented ASCO
(Date:11/24/2009)...re-FirstCall/--QuestDiagnosticsIncorporated(NYSE: ...,informationandservices,announcedthatitisscheduled...enceinNewYorkCity.ThepresentationisscheduledforWed...Duringtheconference,thecompanywillreaffirmits2009g...cometoexceed18%ofrevenues,anddilutedearningspersha...
(Date:11/24/2009)...,Nov.24/PRNewswire/-- EisaiInc.andPfizerIncannoun...asacceptedforreviewEisai,sNewDrugApplication(NDA)f...elease)tabletsforthetreatmentofmoderatetosevereAlz...ntains23mgofdonepezilHClinanextendedrelease,matrix...releaseofthedrug.TheNDAisbasedonahead-to-headclini...
(Date:11/24/2009)...-Accumetrics,Inc.,aprivately-helddeveloperandmarke...-to-usediagnosticsystemformeasuringanindividual,sr...4;andaspirin),announcedtodaythatTimothyI.Still,Pre...efFinancialOfficerofAccumetrics,willbepresentingac...areConferencebeingheldinNewYorkCityonDecember1-2,2...
Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2China Biologic Products Schedules 2009 Second Quarter Earnings Conference Call 13551 1China Biologic Products Schedules 2009 Second Quarter Earnings Conference Call 13551 2Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 1Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 2Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 3Why are autumn leaves red in America and yellow in Europe 3F 9559 1Why are autumn leaves red in America and yellow in Europe 3F 9559 2Why are autumn leaves red in America and yellow in Europe 3F 9559 3
...ate 6 Weeks of Radiation Therapy -, Event: Watch S...ednesday, October 22, 2008, 3 - 4 p.m. by visiti...N, Va., Oct. 6 /PRNewswire/ - Questions raced thro...east cancer in May. Would she have the,tumor remov...emotherapy?, , To view the Multimedia News Releas...
...inking polyphenol-rich 100% Concord grape,juice wa...intake or body,weight, CONCORD, Mass., Oct. 6 Re...grape juice did not cause significant weight gain,...s shown to reduce waist,circumference according to...the American College of Nutrition in Arlington, Vi...
Other Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3
(Date:11/24/2009)... SANBERNARDINO,Calif.,Nov.24/PRNewswire/--Nextmont...nseminarsaimedathelpingHispanic-Americanseniorsund...iorsareencouragedtotakeafreeZumba®Goldclass,a...erengue,salsa,cumbia,rumba,andtango. ,, UnitedH...antsfeelcomfortableandengagedwhenlearningaboutthei...
(Date:11/24/2009)... WASHINGTON,Nov.24/PRNewswire/--TheUnionLaborLifeI...tithasalignedwithVSP(®),()thenation,slargestv...isioninsuranceproductstounions,uniontrustfunds,uni...oraccesspointsofferingservicesincludingcomprehensi...Weunderstandhowimportantqualityeyecareis,"statedBr...
(Date:11/24/2009)... herbal supplement may help ward off peripheral ar...AY, Nov. 24 (HealthDay News) -- Among people aged ...does not prevent heart attacks, stroke or death, a... the popular herbal remedy might help prevent the ... disease, however. , Ginkgo contains nutrients ...
(Date:11/24/2009)...ital death rates didn,t differ greatly between hig..., TUESDAY, Nov. 24 (HealthDay News) -- Do hospita... produce the best results for patients? Maybe not....makes perfect" when it comes to artery-opening pro...ients finds low- and high-volume hospitals perform...
(Date:11/24/2009)...ber 18, 2009 - Oakland, Calif. A study conducted ...cientists identifies a new class of therapeutic ag...ossibly treat colon cancer, the third most deadly ...pid molecules found in soy that research shows may...y, led by Julie Saba, MD, PhD, senior scientist an...
Breaking Medicine News(10 mins):Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Children's Hospital Oakland scientists discover soy component may be key to fighting colon cancer 2
..., TORONTO, Feb. 17 /PRNewswire-FirstCall/ - Bradme...te today on the ongoing Phase III GLASS-ART Trial ...brain cancer (glioblastoma). Bradmer also announce...tiation and patient enrollment from the Company,s ...
...es Company,s Focus on Skilled Geriatric Home Healt...h Services, Inc. (Nasdaq: GTIV ), a leading prov...ced today that it has entered into an Asset Purcha... specialize in pediatric home health care and also...
...rovide solution for early detection of ear infecti...ogging and tweeting away this winter on the topic ...children,s visits to the emergency room. , , "Par...the EarCheck Middle Ear Monitor. "We know they,re ...
...Hopkins, project offers delicious recipes to get u...rdi Gras -- also known as Carnival, or Fat Tuesday...t and meat in millions of homes in preparation for... the word Carnival, arising from the Latin words...
... Landmark study of mobile technology f..., Barcelona, Spain (Vocus)... foundations involved in global health, technology...World Congress an agreement to form the Mobile He...
... Dr. Gregory Sawyer, founder of Los Ga...n Dental Association and the Journal of Evidence-...ence-Based Dentistry Champion Conference. Dr. Saw...vidence-based dentistry. , ...
Other Medicine News:Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 2Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 3Health News:Bradmer provides clinical trial update and announces evaluation of strategic alternatives 4Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 2Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 3Health News:Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches 4Health News:Video: Ear Infections Spark Online Conversations Among Concerned Parents 2Health News:Mardi Gras Gives Everyone a Big Fat Break Because Carnival Means 'So Long' to Meat 2Health News:Leading Foundations to Form mHealth Alliance 2Health News:Leading Foundations to Form mHealth Alliance 3Health News:Leading Foundations to Form mHealth Alliance 4Health News:Dr. Gregory Sawyer, of Los Gatos, Has Been Selected by the American Dental Association for the Evidence-Based Dentistry Champion Conference 2
MG-1000
MAQUET Orthostar II
...atient Surgical Table is built to the same rigorou...ty and general purpose surgical tables, and includ...op rotation for enhanced full body imaging. Standa...a wide variety of accessories. The 1700 Series Tab...
Schaerer Axis 800
Medicine Products: